Cargando…

Profiling Tissue and Biofluid miR-155-5p, miR-155(*), and miR-146a-5p Expression in Graft vs. Host Disease

Introduction: Acute graft vs. host disease (aGvHD) is a frequent complication following allogeneic haematopoeitic transplantation (HSCT). Despite recent advances, there are no universally accepted biomarkers to determine development of aGvHD. MicroRNAs miR-146a and miR-155 have been previously assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crossland, Rachel E., Norden, Jean, Ghimire, Sakhila, Juric, Mateja Kralj, Pearce, Kim F., Lendrem, Clare, Collin, Matthew, Mischak-Weissinger, Eva, Holler, Ernst, Greinix, Hildegard T., Dickinson, Anne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005601/ https://www.ncbi.nlm.nih.gov/pubmed/33790910 http://dx.doi.org/10.3389/fimmu.2021.639171

Ejemplares similares

Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2017)

miR-146a and miR-155 Expression Levels in Acute Graft-Versus-Host Disease Incidence
por: Atarod, Sadaf, et al.
Publicado: (2016)

Combined detection of miR-21-5p, miR-30a-3p, miR-30a-5p, miR-155-5p, miR-216a and miR-217 for screening of early heart failure diseases
por: Ding, Han, et al.
Publicado: (2020)

miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF
por: Varendi, Kärt, et al.
Publicado: (2014)

MiR-155-5p and MiR-203a-3p Are Prognostic Factors in Soft Tissue Sarcoma
por: Greither, Thomas, et al.
Publicado: (2020)

miR-155 in the Resolution of Atherosclerosis
por: Bruen, Robyn, et al.
Publicado: (2019)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

Effect of miR-146a and miR-155 on cardiac xenotransplantation
por: Zhao, Zhicheng, et al.
Publicado: (2016)

miR-155 and miR-122 Expression of Spermatozoa in Obese Subjects
por: López, Paulina, et al.
Publicado: (2018)

MiR-335-3p/miR-155-5p Involved in IGFBP7-AS1–Enhanced Odontogenic Differentiation
por: Zhu, Ningxin, et al.
Publicado: (2022)

Decreased miR-155-5p, miR-15a, and miR-186 Expression in Gastric Cancer Is Associated with Advanced Tumor Grade and Metastasis
por: Zare, Ali, et al.
Publicado: (2019)

Hypermethylation of the miR-155 gene in the whole blood and decreased plasma level of miR-155 in rheumatoid arthritis
por: Kolarz, Bogdan, et al.
Publicado: (2020)

Potential Predictive Value of miR-125b-5p, miR-155-5p and Their Target Genes in the Course of COVID-19
por: Li, Xuewen, et al.
Publicado: (2022)

Exosomal let-7e, miR-21-5p, miR-145, miR-146a and miR-155 in Predicting Antidepressants Response in Patients with Major Depressive Disorder
por: Hung, Yi-Yung, et al.
Publicado: (2021)

miR-125b-5p, miR-155-3p, and miR-214-5p and Target E2F2 Gene in Oral Squamous Cell Carcinoma
por: Gołąbek, Karolina, et al.
Publicado: (2023)

Involvement of miR-142 and miR-155 in Non-Infectious Complications of CVID
por: Amato, Giuliana, et al.
Publicado: (2020)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
por: Qiu, Shuwei, et al.
Publicado: (2013)

MiR-155: An Important Regulator of Neuroinflammation
por: Zingale, Valeria Domenica, et al.
Publicado: (2021)

The Role of miR-155 in Antitumor Immunity
por: Kalkusova, Katerina, et al.
Publicado: (2022)

Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas
por: Dusílková, Nina, et al.
Publicado: (2017)

MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer
por: Park, Sunyoung, et al.
Publicado: (2017)

Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma
por: Slezak-Prochazka, Izabella, et al.
Publicado: (2015)

Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis
por: ZHENG, SHU-RONG, et al.
Publicado: (2012)

Preparation of a miR-155-activating nucleic acid nanoflower to study the molecular mechanism of miR-155 in inflammation
por: Wang, Wenxin, et al.
Publicado: (2022)

Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis
por: Chen, Liang, et al.
Publicado: (2020)

The Effects of Combination of Mimic miR-155-5p and Antagonist miR-324-5p Encapsulated Chitosan in Ovarian Cancer SKOV3
por: Suardi, Rahma B, et al.
Publicado: (2020)

Pap Smear miR-92a-5p and miR-155-5p as Potential Diagnostic Biomarkers of Squamous Intraepithelial Cervical Cancer
por: Azimi, Tahereh, et al.
Publicado: (2021)

Implication of miR-155-5p and miR-143-3p in the Vascular Insulin Resistance and Instability of Human and Experimental Atherosclerotic Plaque
por: González-López, Paula, et al.
Publicado: (2022)

Repression of human activation induced cytidine deaminase by miR-93 and miR-155
por: Borchert, Glen M, et al.
Publicado: (2011)

MiR-210 and miR-155 as potential diagnostic markers for pre-eclampsia pregnancies
por: Gan, Lu, et al.
Publicado: (2017)

MiR-146a and miR-155 polymorphisms in Egyptian patients with Behcet’s disease
por: Shaker, Olfat G., et al.
Publicado: (2021)

Differential Expression of miR-146 and miR-155 in Active and Latent Tuberculosis Infection
por: Alijani, Ebrahim, et al.
Publicado: (2023)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
por: Nemecz, Miruna, et al.
Publicado: (2023)

Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients
por: Eldosoky, Mona A., et al.
Publicado: (2023)

NT21MP negatively regulates paclitaxel-resistant cells by targeting miR-155-3p and miR-155-5p via the CXCR4 pathway in breast cancer
por: Wang, Yueyue, et al.
Publicado: (2018)

miR-155 meets the JAK/STAT pathway
por: Persson, Jenny Liao
Publicado: (2013)

Targeting miR-155 to Treat Experimental Scleroderma
por: Yan, Qingran, et al.
Publicado: (2016)

Quaking and miR-155 interactions in inflammation and leukemogenesis
por: Tili, Esmerina, et al.
Publicado: (2015)

The MicroRNA miR-155 Is Essential in Fibrosis
por: Eissa, Mousa G., et al.
Publicado: (2019)

Data highlighting miR-155 and GAPDH correlation
por: Khanna, Madhu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6ql8os9ksv1dss02jej9kaqeh5